A new study carried out by the scientists of the Gladstone Institutes led by the senior researcher Katerina Akassoglou, Ph.D., shows that many of the new drugs currently being tested may not be sufficient to promote repair within the toxic environment of these cells and identifies a different treatment option that could improve myelin repair.
The study, conducted in collaboration with theUC San Diego and the University of Vienna, in Austria, was published in the magazine Brain.
New drugs for multiple sclerosis: here’s what the research says
In those affected by multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system, called myelin, is damaged. This slows the transmission of signals from the brain to the rest of the body, causing movement difficulties, vision problems and cognitive changes.
Read Also
- Smarth Delivery is trending again Sep 3, 2021
- Mexico vs Panama: schedule, TV channel in Mexico and the United States, online streaming and possible alignments Sep 7, 2021
- The UAE continues to operate its relief air bridge for those affected by the Greek fires Aug 12, 2021
- Luis Miguel reappeared rejuvenated in a Miami shopping center May 21, 2022
- Honor announces a partnership with Microsoft Sep 16, 2021
- The mentioned services available in the application “Da” May 8, 2020
- “I’ll wait for you in intensive care, with a pinch of pleasure”: nurse punished for a post against no vax Jul 30, 2021